Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...
The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...
Following Donald Trump’s funding freeze on HIV treatment and other health programmes, Kenya faces critical decisions in ...
The median (IQR) age of the people living with HIV (PLWH) was 49 (38-57) years, with the recently-arrived GBM having a median ...
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...
In the rural villages of South Africa, U.S. President Donald Trump’s sudden freeze on foreign aid impacts hundreds of ...
A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Legislation that would remove a criminal penalty for intentionally transferring HIV to another person sailed through both the ...